(Total Views: 339)
Posted On: 04/30/2017 8:36:22 PM
Post# of 9162
Mach20,
I will admit I know very little about Nanologix products other than what I read. I am not in this field but am in business for almost 30 years now.
This is from three years ago. Sounds very much like what you are talking about this year.
"Jonathan Faro, MD., of Woman’s Hospital of Texas in Houston, Is presenting a poster titled “Simultaneous Identification of Select Microbial Pathogens and Determination of Antimicrobial Resistance by a Unique Assay” in poster session 210, at display position 2564 in the Poster Hall of the ASM exhibition on 20 May. The technology referenced in the poster is NanoLogix’s patent-pending “N-Assay” Multiwell Microplate"
Is this the GBS test?
Why haven't we got this test off the ground and into the hands of the professionals who would see the advantage of this test?
Why isn't Dr Faro MD using it?
It has been three years.
I will admit I know very little about Nanologix products other than what I read. I am not in this field but am in business for almost 30 years now.
This is from three years ago. Sounds very much like what you are talking about this year.
"Jonathan Faro, MD., of Woman’s Hospital of Texas in Houston, Is presenting a poster titled “Simultaneous Identification of Select Microbial Pathogens and Determination of Antimicrobial Resistance by a Unique Assay” in poster session 210, at display position 2564 in the Poster Hall of the ASM exhibition on 20 May. The technology referenced in the poster is NanoLogix’s patent-pending “N-Assay” Multiwell Microplate"
Is this the GBS test?
Why haven't we got this test off the ground and into the hands of the professionals who would see the advantage of this test?
Why isn't Dr Faro MD using it?
It has been three years.
(3)
(1)
